Susquehanna International Group’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-80,311
| Closed | -$89.9K | – | 13092 |
|
|
2025
Q2 | $89.9K | Buy |
80,311
+55,131
| +219% | +$67.3K | ﹤0.01% | 11853 |
|
|
2025
Q1 | $29K | Sell |
25,180
-7,187
| -22% | -$13.4K | ﹤0.01% | 12022 |
|
|
2024
Q4 | $198K | Buy |
32,367
+12,900
| +66% | +$153K | ﹤0.01% | 10738 |
|
|
2024
Q3 | $322K | Buy |
+19,467
| New | +$213K | ﹤0.01% | 9451 |
|
|
2024
Q1 | – | Sell |
-13,656
| Closed | -$113K | – | 12694 |
|
|
2023
Q4 | $113K | Buy |
+13,656
| New | +$79.3K | ﹤0.01% | 11225 |
|
|
2023
Q3 | – | Sell |
-41,941
| Closed | -$387K | – | 12435 |
|
|
2023
Q2 | $387K | Buy |
+41,941
| New | +$470K | ﹤0.01% | 8909 |
|
|
2022
Q2 | – | Sell |
-18,578
| Closed | -$331K | – | 13355 |
|
|
2022
Q1 | $497K | Sell |
18,578
-17,116
| -48% | -$319K | ﹤0.01% | 8996 |
|
|
2021
Q4 | $1.05M | Buy |
35,694
+2,709
| +8% | +$135K | ﹤0.01% | 7176 |
|
|
2021
Q3 | $2.17M | Buy |
32,985
+24,161
| +274% | +$1.85M | ﹤0.01% | 5650 |
|
|
2021
Q2 | $734K | Buy |
8,824
+4,958
| +128% | +$367K | ﹤0.01% | 8625 |
|
|
2021
Q1 | $296K | Buy |
3,866
+1,146
| +42% | +$104K | ﹤0.01% | 10628 |
|
|
2020
Q4 | $240K | Sell |
2,720
-4,559
| -63% | -$320K | ﹤0.01% | 9733 |
|
|
2020
Q3 | $537K | Buy |
+7,279
| New | +$431K | ﹤0.01% | 7514 |
|
Other funds holding IGMS
Susquehanna International Group's IGMS Position: Q3 2025 in Review
Susquehanna International Group sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 80,311 shares — an estimated $89.9K sold.
Susquehanna International Group first reported a position in IGMS in Q3 2020 and held it in 13 quarters. The position peaked at $2.17M in Q3 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Susquehanna International Group reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Susquehanna International Group sold 80,311 IGM Biosciences shares in Q3 2025, an estimated $89.9K.
- Susquehanna International Group first reported a position in IGM Biosciences in Q3 2020 and held it in 13 quarters.
- Susquehanna International Group's IGM Biosciences position peaked at $2.17M in Q3 2021.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.